Study of the Telomere-telomerase System and the Expression of Candidate Genes in the Leukocytes of Patients With Depressive Disorder: Search for Peripheral Markers of Somatic Stress
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Telomere length
研究概览
简要总结
The mechanisms of oxidative stress and inflammation involved in mood disorders are factors of chronicity and severity. These mechanisms induce a phenomenon of accelerated cellular senescence and are reflected by alterations in systemic gene expression detectable in leukocytes in peripheral blood. The genetic markers of these mechanisms are clinically significant markers. The identification of new genetic markers will make it possible to improve evaluations of the severity and somatic consequences of depressive syndromes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Persons who have given their written informed consent
- •absence of a diagnosis of major depressive disorder throughout the study and no history of psychiatric disorders
- •diagnosis of a first episode of a major depressive disorder
- •diagnosis of a recurrent major depressive disorder (at least three episodes) with or without resistance to therapy
- •the diagnosis of major depressive disorder with characteristics of melancholy must be clearly mentioned in the case report form but is not a reason for not being included in the study
- •the presence of a recent or older attempted suicide must lead to a careful clinical assessment of the diagnosis of depressive disorder and must be clearly mentioned in the case report form.
排除标准
- •Persons not covered by the national Health Insurance Agency
- •Psychotic or bipolar disorders
- •Severe personality disorders
- •cardiovascular disease, proven inflammatory disease and cancer
- •persons unable to give their consent personally,
- •persons in emergency situations,
- •pregnant women,
- •breast-feeding women
研究组 & 干预措施
patients with recurrent depressive disorder
a group of patients with recurrent depressive disorder according to DSM-IV-TR including depressive episodes with melancholic features (at least three episodes of depression)
干预措施: telomere length (Other)
control group
patient with no depressive disorder during the study period and no psychiatric history
干预措施: telomere length (Other)
patients with a first episode of major depressive disorder
a group of patients with a first episode of major depressive disorder according to DSM-IV-TR including depressive episodes with melancholic features
干预措施: telomere length (Other)
结局指标
主要结局
Telomere length
时间窗: participants will be followed for the duration of hospital stay, an expected average of 6 months
次要结局
- level of oxidative stress.(participants will be followed for the duration of hospital stay, an expected average of 6 months)